Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong
· Delayed Price · Currency is HKD 22.10
+0.25 (1.14%)
Apr 17, 2025, 4:08 PM HKT
HKG:3692 Revenue
In the year 2024, Hansoh Pharmaceutical Group Company had annual revenue of 12.26B CNY with 21.35% growth. Hansoh Pharmaceutical Group Company had revenue of 5.76B in the half year ending December 31, 2024, with 16.32% growth.
Revenue
12.26B CNY
Revenue Growth
+21.35%
P/S Ratio
10.05
Revenue / Employee
1.36M CNY
Employees
8,989
Market Cap
131.15B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |
| Sino Biopharmaceutical | 30.72B |